Jane Street Group, LLC Spero Therapeutics, Inc. Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.68 - $2.2 $10,537 - $34,091	15,496 New	15,496 $31,000
Q2 2022 Aug 16, 2022	SELL	$0.74 - $7.44 $11,560 - $116,227	-15,622 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$7.87 - $15.15 $122,945 - $236,673	15,622 New	15,622 $136,000
Q2 2021 Aug 16, 2021	SELL	$12.22 - $15.79 $140,481 - $181,521	-11,496 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$13.23 - $21.48 $152,092 - $246,934	11,496 New	11,496 $169,000

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.3M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.